Welcome to our dedicated page for Breeze Holdings Acquisition news (Ticker: BREZ), a resource for investors and traders seeking the latest updates and insights on Breeze Holdings Acquisition stock.
Breeze Holdings Acquisition Corp. (historically associated with the symbol BREZ) generated news primarily as a special purpose acquisition company working to complete business combinations rather than as an operating business. Its press releases and SEC-referenced announcements focus on merger agreements, stockholder votes, listing status, and the transition of value to the operating companies it sought to combine with.
News coverage for Breeze includes multiple stages of proposed transactions. Earlier releases describe a business combination agreement with TV Ammo, Inc., also known as True Velocity, an advanced technology and composite manufacturing company focused on composite-cased ammunition, weapon systems, and suppressors. These items highlight the filing of a registration statement on Form S-4, conference participation, and transaction timelines.
Subsequent news documents a shift in strategy, including the termination of the TV Ammo business combination and Breeze’s stated intention to continue pursuing another target. Later, Breeze announced a definitive agreement to merge with YD Biopharma Limited, a clinical-stage biopharmaceutical company concentrating on cancer prevention medical diagnostics and exosome-based therapeutics. Follow-up releases detail patents and authorizations obtained by YD Biopharma, as well as the structure and expected listing of the combined company on the Nasdaq Capital Market.
More recent news reports that Breeze stockholders approved the business combination with YD Biopharma at a special meeting, with the combined company to be named YD Bio Limited and its ordinary shares expected to trade under the ticker “YDES.” Other items cover extensions of the SPAC’s business combination deadline, movement of its securities to OTCQX and OTCQB markets, and updates on trust account redemptions.
Investors and researchers using this news page can review the full sequence of announcements around BREZ, including transaction milestones, regulatory filings referenced in the releases, and the evolution from an initial SPAC listing to an approved merger with a biopharmaceutical company. This historical news record helps explain how Breeze’s capital and listing structure were used to support its chosen combination partners.
Breeze Holdings Acquisition Corp. (NASDAQ: BREZ) announced receipt of a notice from Nasdaq for non-compliance with Listing Rule 5250(c)(1) due to a late filing of its Q1 2021 Form 10-Q. The notice, dated May 28, 2021, does not immediately affect trading or listing. The delay is attributed to the evaluation of the SEC's Staff Statement on SPAC warrants, preventing timely filing by the due date of May 17, 2021. Breeze has 60 days to submit a compliance plan, with a potential extension of up to 180 days for regaining compliance.